Progression-Free and Overall Survival of Patients With ALK Rearrangement–Positive Non–Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib

Autor: Watanabe, Satomi, Hayashi, Hidetoshi, Okamoto, Kunio, Fujiwara, Kimiko, Hasegawa, Yoshikazu, Kaneda, Hiroyasu, Tanaka, Kaoru, Takeda, Masayuki, Nakagawa, Kazuhiko
Zdroj: In Clinical Lung Cancer November 2016 17(6):528-534
Databáze: ScienceDirect